GB1357813A - Effervescent composition for the treatment of heart diseases - Google Patents
Effervescent composition for the treatment of heart diseasesInfo
- Publication number
- GB1357813A GB1357813A GB4109971A GB4109971A GB1357813A GB 1357813 A GB1357813 A GB 1357813A GB 4109971 A GB4109971 A GB 4109971A GB 4109971 A GB4109971 A GB 4109971A GB 1357813 A GB1357813 A GB 1357813A
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- heart diseases
- composition
- sept
- bicarbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1357813 Pharmaceutical compositions SIPHAR SA 2 Sept 1971 [7 Sept 1970] 41099/71 Heading A5B Pharmaceutical compositions having cardiostimulant activity, for the treatment of heart diseases by oral administration, comprise creatinol-O-phosphate having the formula: in combination with a pharmacologically acceptable carrier and effervescent materials comprising an alkali metal carbonate or bicarbonate (such as sodium or potassium carbonate and/or bicarbonate). The composition may also contain fumaric, tartaric or citric acid, vitamins C and/or B 6 , and excipient materials such as glucose. The composition may be in the form of a granulated powder or tablet.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE93658 | 1970-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1357813A true GB1357813A (en) | 1974-06-26 |
Family
ID=3841391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4109971A Expired GB1357813A (en) | 1970-09-07 | 1971-09-02 | Effervescent composition for the treatment of heart diseases |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE2144584A1 (en) |
FR (1) | FR2106352B1 (en) |
GB (1) | GB1357813A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294579B1 (en) | 1999-10-11 | 2001-09-25 | Joseph W. Carnazzo | Method for improving delivery of tyrosine supplementation |
WO2005082165A1 (en) * | 2004-03-01 | 2005-09-09 | Degussa Ag | Use of guanidine compounds as physiological restoratives in the form of food supplements and fodder additives, in cosmetic preparations and as plant restoratives |
EP2276494A1 (en) * | 2008-04-09 | 2011-01-26 | John H. Owoc | Stable aqueous compositions comprising bioactive creatine species |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1087883A (en) * | 1982-02-02 | 1983-08-11 | Bayer Aktiengesellschaft | Water dispersible, soluble granules |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH448991A (en) * | 1964-10-28 | 1967-12-31 | Siphar Sa | Process for the preparation of a phosphorylated therapeutic guanidine |
-
1971
- 1971-09-02 GB GB4109971A patent/GB1357813A/en not_active Expired
- 1971-09-06 DE DE19712144584 patent/DE2144584A1/en not_active Withdrawn
- 1971-09-07 FR FR7132287A patent/FR2106352B1/fr not_active Expired
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294579B1 (en) | 1999-10-11 | 2001-09-25 | Joseph W. Carnazzo | Method for improving delivery of tyrosine supplementation |
WO2005082165A1 (en) * | 2004-03-01 | 2005-09-09 | Degussa Ag | Use of guanidine compounds as physiological restoratives in the form of food supplements and fodder additives, in cosmetic preparations and as plant restoratives |
EP2276494A1 (en) * | 2008-04-09 | 2011-01-26 | John H. Owoc | Stable aqueous compositions comprising bioactive creatine species |
EP2276494A4 (en) * | 2008-04-09 | 2011-10-19 | John H Owoc | Stable aqueous compositions comprising bioactive creatine species |
US8372821B2 (en) | 2008-04-09 | 2013-02-12 | Jack H. Owoc | Stable aqueous compositions comprising bioactive creatine species |
US9114150B2 (en) | 2008-04-09 | 2015-08-25 | Jho Intellectual Property Holdings, Llc | Stable aqueous compositions comprising bioactive creatine species |
Also Published As
Publication number | Publication date |
---|---|
DE2144584A1 (en) | 1972-04-06 |
FR2106352A1 (en) | 1972-05-05 |
FR2106352B1 (en) | 1975-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1171691A (en) | Lond-Acting Oral Carrier | |
ES485065A1 (en) | Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof | |
ES352030A1 (en) | Urate oxidase and process for the production thereof | |
GB1388358A (en) | Taste-improving formulations of oral penicillins | |
GB1256968A (en) | ||
GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
GB1202148A (en) | Pharmaceutical compositions | |
GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
GB1270049A (en) | New pharmaceutical product | |
GB1327560A (en) | Effervescent pharmaceutical preparations | |
GB1203328A (en) | Pharmaceutical compositions | |
GB1424611A (en) | Pharmaceutical compositions | |
IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
IE35711L (en) | Pharmaceutical compositions | |
GB1321466A (en) | N-acetyl-6-amino-hexanoic acid derivative process for its production and pharmaceutical compositions containing the derivative | |
GB1246315A (en) | Pharmaceutical compositions | |
ES8303915A1 (en) | Pharmaceutical composition of phosphonomicin in tablet form. | |
GB1394397A (en) | Chlorphenesin derivatives and method of making same | |
JPS57179118A (en) | Antitumor agent | |
GB1287433A (en) | Pharmaceutical compositions | |
GB1360032A (en) | 2-thio-5-azocytosine and its nucleosides | |
GB1454872A (en) | Anticonvulsant | |
ES383340A1 (en) | P-(acetoacetamidoalkyl)benzenesulfonamide derivatives | |
ES372134A1 (en) | Novel pyridine derivatives, compositions containing the same, and methods of preparing the same | |
ES341427A1 (en) | Pyrazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |